|
5OSA
GLIC-GABAAR alpha1 chimera crystallized at pH4.6
Deposited 2017-08-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain A
250–338(89 aa)
Chain A
417–455(39 aa)
Chain B
250–338(89 aa)
Chain B
417–455(39 aa)
Chain C
250–338(89 aa)
Chain C
417–455(39 aa)
Chain D
250–338(89 aa)
Chain D
417–455(39 aa)
Chain E
250–338(89 aa)
Chain E
417–455(39 aa)
|
Not recorded
|
ACT ACETATE ION × 8
CL CHLORIDE ION × 7
D12 DODECANE × 8
Y01 CHOLESTEROL HEMISUCCINATE × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;289.15 K;100 mM NaCl, 100 mM sodium acetate pH 4.6, 12 % PEG 6000
|
Resolution 2.75 Å
R-free 0.229
|
|
5OSB
GLIC-GABAAR alpha1 chimera crystallized in complex with THDOC at pH4.5
Deposited 2017-08-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain A
250–338(89 aa)
Chain A
417–455(39 aa)
Chain B
250–338(89 aa)
Chain B
417–455(39 aa)
Chain C
250–338(89 aa)
Chain C
417–455(39 aa)
Chain D
250–338(89 aa)
Chain D
417–455(39 aa)
Chain E
250–338(89 aa)
Chain E
417–455(39 aa)
|
Not recorded
|
A8Z Tetrahydrodeoxycorticosterone × 5
ACT ACETATE ION × 5
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;289 K;12-16% PEG4000, 100mM NaCl, 100 mM Li2SO4, 100mM sodium acetate pH4-4.5
|
Resolution 3.80 Å
R-free 0.290
|
|
5OSC
GLIC-GABAAR alpha1 chimera crystallized in complex with pregnenolone sulfate at pH 4.5
Deposited 2017-08-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain A
417–455(39 aa)
Chain B
417–455(39 aa)
Chain C
417–455(39 aa)
Chain D
417–455(39 aa)
Chain E
417–455(39 aa)
|
Not recorded
|
ACT ACETATE ION × 8
CL CHLORIDE ION × 5
A8W Pregnenolone sulfate × 5
Y01 CHOLESTEROL HEMISUCCINATE × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;289 K;12-16% PEG 4000, 100 mM NaCl, 100 mM Li2S04, 100 mM sodium acetate pH 4-5
|
Resolution 3.10 Å
R-free 0.246
|
|
8FOI
Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with GABA and allopregnanolone
Deposited 2022-12-30
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain A
1–455(455 aa)
Chain C
1–455(455 aa)
|
Not recorded
|
PIO [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate × 2
D12 DODECANE × 17
OCT N-OCTANE × 17
POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 5
ABU GAMMA-AMINO-BUTANOIC ACID × 2
Y4B allopregnanolone × 2
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.50 Å
|
|
8G4O
Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with didesethylflurazepam and endogenous GABA
Deposited 2023-02-10
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain A
1–455(455 aa)
Chain C
1–455(455 aa)
|
Not recorded
|
ABU GAMMA-AMINO-BUTANOIC ACID × 2
YNL (5M)-1-(2-aminoethyl)-7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.06 Å
|
|
8G4X
Native GABA-A receptor from the mouse brain, meta-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA and allopregnanolone
Deposited 2023-02-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
1–455(455 aa)
|
Not recorded
|
PIO [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate × 2
ABU GAMMA-AMINO-BUTANOIC ACID × 2
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
Y4B allopregnanolone × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.56 Å
|
|
8G5F
Native GABA-A receptor from the mouse brain, ortho-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA and allopregnanolone
Deposited 2023-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain C
1–455(455 aa)
|
Not recorded
|
PIO [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate × 2
Y4B allopregnanolone × 2
ABU GAMMA-AMINO-BUTANOIC ACID × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.64 Å
|
|
8G5G
Native GABA-A receptor from the mouse brain, meta-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid
Deposited 2023-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
1–455(455 aa)
|
Not recorded
|
PIO [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate × 2
Y4B allopregnanolone × 1
ABU GAMMA-AMINO-BUTANOIC ACID × 2
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
R5R Zolpidem × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.94 Å
|
|
8G5H
Native GABA-A receptor from the mouse brain, ortho-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid
Deposited 2023-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain C
1–455(455 aa)
|
Not recorded
|
ABU GAMMA-AMINO-BUTANOIC ACID × 2
PIO [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate × 2
R5R Zolpidem × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
Y4B allopregnanolone × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.89 Å
|